Clinical Trial Update: Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a combination stem cell therapy for severe leg ischemia has completed the study, with status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Vascular Disease

Drugs mentioned

• Combination Stem Cell Therapy

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Critical Limb Ischemia, Peripheral Vascular Disease | Phase 1 | Status: COMPLETED